|
Poveda-Garcia A, Ruiz E, Moreno MJ, Espanol I, Sanchez-Salinas A, Garcia-Hernandez AM, Blanquer M, Martinez I, Sanchez-Villalobos M, Garcia Garay MC, Salido E, Heredia A, Navarro-Almenzar B, Monserrat J, Sanchez-Salas JA, Martinez-Mellado AJ, Minguela A, Campillo JA, Lopez-Hernandez R, Galian JA, Moraleda JM, Roldan V, Cabanas V. Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis. Bone Marrow Transplant. 2024 Nov;59(11):1625-1627. doi: 10.1038/s41409-024-02404-1. Epub 2024 Aug 26. No abstract available. PubMed PMID: 39187602.
AÑO: 2024; IF: 4.5
|
39187602
|
Sanchez-Villalobos M, Campos Banos E, Martinez-Balsalobre E, Navarro-Ramirez V, Videla MAB, Pinilla M, Guillen-Navarro E, Salido-Fierrez E, Perez-Oliva AB. Whole Blood Transcriptome Analysis in Congenital Anemia Patients. Int J Mol Sci. 2024 Oct 31;25(21):11706. doi: 10.3390/ijms252111706. PubMed PMID: 39519257; PubMed Central PMCID: PMC11546763.
AÑO: 2024; IF: 4.9
|
|
Beltran A, Sanchez-Villalobos M, Salido E, Alguero C, Campos E, Perez-Oliva AB, Blanquer M, Moraleda JM. Flow Cytometry as a New Accessible Method to Evaluate Diagnostic Osmotic Changes in Patients with Red Blood Cell Membrane Defects. Biomedicines. 2024 Jul 19;12(7):1607. doi: 10.3390/biomedicines12071607. PubMed PMID: 39062184; PubMed Central PMCID: PMC11274888.
AÑO: 2024; IF: 3.9
|
|
Sanchez-Villalobos M, Campos Banos E, Juan Fita MJ, Egea Mellado JM, Gonzalez Gallego I, Beltran Videla A, Berenguer Piqueras M, Bermudez Cortes M, Moraleda Jimenez JM, Guillen Navarro E, Salido Fierrez E, Perez-Oliva AB. A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain). Int J Neonatal Screen. 2023 Oct 10;9(4):55. doi: 10.3390/ijns9040055. PubMed PMID: 37873846; PubMed Central PMCID: PMC10594431.
AÑO: 2023; IF: 3.5
|
|
Sanchez Villalobos M, Salido Fierrez E, Martinez Nieto J, Garcia Garay MC, Beltran Videla A, Perez Oliva AB, Blanquer Blanquer M, Moraleda Jimenez JM. Case Report: alpha-Spectrin Mutation Associated with alphaLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis. Hematol Rep. 2022 Oct 8;14(4):300-304. doi: 10.3390/hematolrep14040043. PubMed PMID: 36278520; PubMed Central PMCID: PMC9589974.
AÑO: 2022
|